Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection — An observational cohort study
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference35 articles.
1. Fidaxomicin is an inhibitor of the initiation of bacterial RNA synthesis;Artsimovitch;Clin Infect Dis,2012
2. Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study;Barbut;Clin Microbiol Infect,2019
3. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI);Bauer;Clin Microbiol Infect,2009
4. Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis;Beinortas;Lancet Infect Dis,2018
5. Diagnosis and therapy of Clostridium difficile infection: Czech national guidelines;Beneš;Klin Mikrobiol Infekc Lek,2014
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of fidaxomicin versus vancomycin in the treatment of Clostridium difficile infection: A systematic meta-analysis;Medicine;2024-08-09
2. Comparative effectiveness of vancomycin and metronidazole on event-free survival after initial infection in patients with Clostridioides difficile—a German multicentre cohort study;Clinical Microbiology and Infection;2024-08
3. Characterization of Clostridioides difficile Persister Cells and Their Role in Antibiotic Tolerance;Microorganisms;2024-07-09
4. Clostridioides difficile infection epidemiology during the COVID-19 pandemic in Greece;Future Microbiology;2024-06-24
5. The Clinical Effectiveness of Fidaxomicin Compared to Vancomycin in the Treatment of Clostridioides difficile Infection, A Single-Center Real-World Experience;The Journal of Infectious Diseases;2024-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3